We are live on ! Find out more
CCM

Chicago Capital Management Portfolio holdings

AUM $112M
1-Year Est. Return 76.54%
This Fund
S&P 500
This Quarter Est. Return
+11.6%
1 Year Est. Return
+76.54%
3 Year Est. Return
+294.65%
5 Year Est. Return
+1,991.46%
10 Year Est. Return
+177,846.73%
AUM
$112M
AUM Growth
-$24.3M
Cap. Flow
-$82.8M
Cap. Flow %
-74.12%
Top 10 Hldgs %
59.62%
Holding
41
New
5
Increased
1
Reduced
–
Closed
13

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$13.5M
2
TRML
Tourmaline Bio
TRML
+$3.12M
3
PBBK
PB Bankshares
PBBK
+$2.74M
4
CCRD
CoreCard
CCRD
+$1.8M
5
BFIN
BankFinancial
BFIN
+$341K

Top Sells

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$9.41M
2
BPMC
Blueprint Medicines
BPMC
+$7.69M
3
OPOF
Old Point Financial
OPOF
+$7.27M
4
VIGL
Vigil Neuroscience
VIGL
+$3.84M
5
PWOD
Penns Woods Bancorp
PWOD
+$2.36M

Sector Composition

Rank Sector Weight
1 Healthcare 17.18%
2 Financials 3.34%
3 Technology 1.57%
4 Energy 0%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRNA
1
DELISTED
Verona Pharma
VRNA
$13.8M 12.37%
+129,600
New +$13.5M
TRML
2
DELISTED
Tourmaline Bio
TRML
$5.38M 4.81%
+112,406
New +$3.12M
PBBK
3
DELISTED
PB Bankshares
PBBK
$2.8M 2.5%
+145,751
New +$2.74M
HPE.PRC
4
Hewlett Packard Enterprise 7.625% Series C Preferred Stock
HPE.PRC
$3.7B
$2.23M 2%
32,900
– –
CCRD
5
DELISTED
CoreCard
CCRD
$1.75M 1.57%
+65,059
New +$1.8M
CFSB
6
DELISTED
CFSB Bancorp
CFSB
$588K 0.53%
41,424
+6,566
+19% +$91.6K
BFIN
7
DELISTED
BankFinancial
BFIN
$346K 0.31%
+28,752
New +$341K
BPMC
8
DELISTED
Blueprint Medicines
BPMC
– –
-60,000
Closed -$7.69M
CTLP
9
DELISTED
Cantaloupe
CTLP
– –
-50,692
Closed -$557K
EBTC
10
DELISTED
Enterprise Bancorp
EBTC
– –
-7,859
Closed -$312K
GMS
11
DELISTED
GMS Inc
GMS
– –
-15,000
Closed -$1.63M
HES
12
DELISTED
Hess
HES
– –
-5,000
Closed -$693K
NVEE
13
DELISTED
NV5 Global
NVEE
– –
-10,000
Closed -$231K
OPOF
14
DELISTED
Old Point Financial
OPOF
– –
-185,296
Closed -$7.27M
PWOD
15
DELISTED
Penns Woods Bancorp
PWOD
– –
-77,579
Closed -$2.36M
SSBK
16
DELISTED
Southern States Bancshares
SSBK
– –
-46,451
Closed -$1.69M
SWTX
17
DELISTED
SpringWorks Therapeutics
SWTX
– –
-200,230
Closed -$9.41M
TGI
18
DELISTED
Triumph Group
TGI
– –
-85,000
Closed -$2.19M
VERV
19
DELISTED
Verve Therapeutics
VERV
– –
-125,377
Closed -$1.41M
VIGL
20
DELISTED
Vigil Neuroscience
VIGL
– –
-482,769
Closed -$3.84M

Similar funds

PC
Parrish Capital Kennesaw, Georgia $112M AUM
PFS
Professional Financial Solutions Falls Chruch, Virginia $112M AUM
VCM
Veradace Capital Management Dallas, Texas $112M AUM
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
AIC
Argus Investors Counsel New York $112M AUM 25.83% 1-Year Est. Return
APFP
Action Point Financial Planning Grand Rapids, Michigan $112M AUM
AIP
Arrowpoint Investment Partners Singapore $113M AUM 73.91% 1-Year Est. Return
MWP
Momentum Wealth Planning Estero, Florida $113M AUM 26.08% 1-Year Est. Return

Chicago Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Chicago Capital Management held 41 positions worth $112M, down 18% from $136M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Chicago Capital Management withdrew a net $82.8M in Q3 2025, closing 13 positions. Its most notable exit was SpringWorks Therapeutics, an estimated $9.41M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

Against the trend, Chicago Capital Management opened a new position in Verona Pharma worth $13.8M.

  • Chicago Capital Management's largest Q3 2025 buy was Verona Pharma: 129,600 shares worth $13.8M.
  • Chicago Capital Management added most to CFSB Bancorp in Q3 2025, an estimated $91.6K increase.
  • Chicago Capital Management fully exited SpringWorks Therapeutics in Q3 2025, selling an estimated $9.41M.
  • Chicago Capital Management's ten largest holdings make up 60% of its $112M portfolio in Q3 2025.
  • Chicago Capital Management opened 5 new positions and closed 13 in Q3 2025.
  • Chicago Capital Management's portfolio value fell 18% quarter-over-quarter to $112M.

Based on Chicago Capital Management's 13F filing for Q3 2025, filed 7 Nov 2025.